Trump said that Washington not informing allies about the strikes on Iran was because "we wanted surprise." He went on to say, "Who knows better about that. Why didn't you tell me about Pearl Harbor?

Oil fell as Bessent said the U.S. may free up stranded Iranian crude. Israel says it is helping efforts to reopen the Strait of Hormuz. Citi raised its near-term oil forecast as the Iran conflict ...

Apollo's Co-Head of Private Equity David Sambur said the worst is yet to come for software stocks. Sambur said investors continue to question the sector's revenue and gross margin models given ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer said that investors should hold their noses and buy. Cramer points to the S&P Short Range Oscillator's extremely oversold levels as a marker for a ...

OpenAI will combine its web browser, ChatGPT app and Codex app into a singular desktop super app. Fidji Simo, OpenAI's CEO of Applications, will oversee the change with assistance from OpenAI ...

The U.S. Attorney's Office for the Southern District of New York is arguing that people affiliated with an unnamed U.S. server maker illegally diverted billions in equipment containing Nvidia ...

The Federal Communications Commission said on Thursday it has approved the sale of some local broadcast TV stations ...

Asia-Pacific markets were set to fall Friday following volatile trading on Wall Street overnight as investors sold assets from government bonds to equities and metals amid the Ira ...

Mad Money' host Jim Cramer talks the bull case for Dell Technologies. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get ...

Immunitybio, Skyworks Solutions, Stellantis, Element Solutions, GE Vernova, and Carnival. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC ...

Signet Jewelers CEO J.K. Symancyk joins 'Mad Money' host Jim Cramer to talk the state of the jewelry market, its quarterly ...

Mad Money' host Jim Cramer looks at a buying opportunity in a winning pharmaceutical stock amid market turmoil.